Characterization of the Raf kinase inhibitory protein (RKIP) binding pocket: NMR-based screening identifies small-molecule ligands.

<h4>Background</h4>Raf kinase inhibitory protein (RKIP), also known as phoshaptidylethanolamine binding protein (PEBP), has been shown to inhibit Raf and thereby negatively regulate growth factor signaling by the Raf/MAP kinase pathway. RKIP has also been shown to suppress metastasis. We...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Anne N Shemon, Gary L Heil, Alexey E Granovsky, Mathew M Clark, Dan McElheny, Alexander Chimon, Marsha R Rosner, Shohei Koide
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2010
Materias:
R
Q
Acceso en línea:https://doaj.org/article/599a1f1f544e4bb28a7ae4ba60f27bbd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:599a1f1f544e4bb28a7ae4ba60f27bbd
record_format dspace
spelling oai:doaj.org-article:599a1f1f544e4bb28a7ae4ba60f27bbd2021-12-02T20:21:53ZCharacterization of the Raf kinase inhibitory protein (RKIP) binding pocket: NMR-based screening identifies small-molecule ligands.1932-620310.1371/journal.pone.0010479https://doaj.org/article/599a1f1f544e4bb28a7ae4ba60f27bbd2010-05-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20463977/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Raf kinase inhibitory protein (RKIP), also known as phoshaptidylethanolamine binding protein (PEBP), has been shown to inhibit Raf and thereby negatively regulate growth factor signaling by the Raf/MAP kinase pathway. RKIP has also been shown to suppress metastasis. We have previously demonstrated that RKIP/Raf interaction is regulated by two mechanisms: phosphorylation of RKIP at Ser-153, and occupation of RKIP's conserved ligand binding domain with a phospholipid (2-dihexanoyl-sn-glycero-3-phosphoethanolamine; DHPE). In addition to phospholipids, other ligands have been reported to bind this domain; however their binding properties remain uncharacterized.<h4>Methods/findings</h4>In this study, we used high-resolution heteronuclear NMR spectroscopy to screen a chemical library and assay a number of potential RKIP ligands for binding to the protein. Surprisingly, many compounds previously postulated as RKIP ligands showed no detectable binding in near-physiological solution conditions even at millimolar concentrations. In contrast, we found three novel ligands for RKIP that specifically bind to the RKIP pocket. Interestingly, unlike the phospholipid, DHPE, these newly identified ligands did not affect RKIP binding to Raf-1 or RKIP phosphorylation. One out of the three ligands displayed off target biological effects, impairing EGF-induced MAPK and metabolic activity.<h4>Conclusions/significance</h4>This work defines the binding properties of RKIP ligands under near physiological conditions, establishing RKIP's affinity for hydrophobic ligands and the importance of bulky aliphatic chains for inhibiting its function. The common structural elements of these compounds defines a minimal requirement for RKIP binding and thus they can be used as lead compounds for future design of RKIP ligands with therapeutic potential.Anne N ShemonGary L HeilAlexey E GranovskyMathew M ClarkDan McElhenyAlexander ChimonMarsha R RosnerShohei KoidePublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 5, Iss 5, p e10479 (2010)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Anne N Shemon
Gary L Heil
Alexey E Granovsky
Mathew M Clark
Dan McElheny
Alexander Chimon
Marsha R Rosner
Shohei Koide
Characterization of the Raf kinase inhibitory protein (RKIP) binding pocket: NMR-based screening identifies small-molecule ligands.
description <h4>Background</h4>Raf kinase inhibitory protein (RKIP), also known as phoshaptidylethanolamine binding protein (PEBP), has been shown to inhibit Raf and thereby negatively regulate growth factor signaling by the Raf/MAP kinase pathway. RKIP has also been shown to suppress metastasis. We have previously demonstrated that RKIP/Raf interaction is regulated by two mechanisms: phosphorylation of RKIP at Ser-153, and occupation of RKIP's conserved ligand binding domain with a phospholipid (2-dihexanoyl-sn-glycero-3-phosphoethanolamine; DHPE). In addition to phospholipids, other ligands have been reported to bind this domain; however their binding properties remain uncharacterized.<h4>Methods/findings</h4>In this study, we used high-resolution heteronuclear NMR spectroscopy to screen a chemical library and assay a number of potential RKIP ligands for binding to the protein. Surprisingly, many compounds previously postulated as RKIP ligands showed no detectable binding in near-physiological solution conditions even at millimolar concentrations. In contrast, we found three novel ligands for RKIP that specifically bind to the RKIP pocket. Interestingly, unlike the phospholipid, DHPE, these newly identified ligands did not affect RKIP binding to Raf-1 or RKIP phosphorylation. One out of the three ligands displayed off target biological effects, impairing EGF-induced MAPK and metabolic activity.<h4>Conclusions/significance</h4>This work defines the binding properties of RKIP ligands under near physiological conditions, establishing RKIP's affinity for hydrophobic ligands and the importance of bulky aliphatic chains for inhibiting its function. The common structural elements of these compounds defines a minimal requirement for RKIP binding and thus they can be used as lead compounds for future design of RKIP ligands with therapeutic potential.
format article
author Anne N Shemon
Gary L Heil
Alexey E Granovsky
Mathew M Clark
Dan McElheny
Alexander Chimon
Marsha R Rosner
Shohei Koide
author_facet Anne N Shemon
Gary L Heil
Alexey E Granovsky
Mathew M Clark
Dan McElheny
Alexander Chimon
Marsha R Rosner
Shohei Koide
author_sort Anne N Shemon
title Characterization of the Raf kinase inhibitory protein (RKIP) binding pocket: NMR-based screening identifies small-molecule ligands.
title_short Characterization of the Raf kinase inhibitory protein (RKIP) binding pocket: NMR-based screening identifies small-molecule ligands.
title_full Characterization of the Raf kinase inhibitory protein (RKIP) binding pocket: NMR-based screening identifies small-molecule ligands.
title_fullStr Characterization of the Raf kinase inhibitory protein (RKIP) binding pocket: NMR-based screening identifies small-molecule ligands.
title_full_unstemmed Characterization of the Raf kinase inhibitory protein (RKIP) binding pocket: NMR-based screening identifies small-molecule ligands.
title_sort characterization of the raf kinase inhibitory protein (rkip) binding pocket: nmr-based screening identifies small-molecule ligands.
publisher Public Library of Science (PLoS)
publishDate 2010
url https://doaj.org/article/599a1f1f544e4bb28a7ae4ba60f27bbd
work_keys_str_mv AT annenshemon characterizationoftherafkinaseinhibitoryproteinrkipbindingpocketnmrbasedscreeningidentifiessmallmoleculeligands
AT garylheil characterizationoftherafkinaseinhibitoryproteinrkipbindingpocketnmrbasedscreeningidentifiessmallmoleculeligands
AT alexeyegranovsky characterizationoftherafkinaseinhibitoryproteinrkipbindingpocketnmrbasedscreeningidentifiessmallmoleculeligands
AT mathewmclark characterizationoftherafkinaseinhibitoryproteinrkipbindingpocketnmrbasedscreeningidentifiessmallmoleculeligands
AT danmcelheny characterizationoftherafkinaseinhibitoryproteinrkipbindingpocketnmrbasedscreeningidentifiessmallmoleculeligands
AT alexanderchimon characterizationoftherafkinaseinhibitoryproteinrkipbindingpocketnmrbasedscreeningidentifiessmallmoleculeligands
AT marsharrosner characterizationoftherafkinaseinhibitoryproteinrkipbindingpocketnmrbasedscreeningidentifiessmallmoleculeligands
AT shoheikoide characterizationoftherafkinaseinhibitoryproteinrkipbindingpocketnmrbasedscreeningidentifiessmallmoleculeligands
_version_ 1718374108668887040